Sema3G was also found to inhibit the invasion and migration of gliobalstoma cells [155] and to inhibit the development of tumors from MDA-MB-435 breast cancer cells in which it was expressed ectopically, suggesting that it too can directly affect the development of tumors from tumor cells that express sema3G receptors [108]. Here, SEMA3G is linked to neoplasm.